Composition for leucopenia after radiotherapy and chemotherapy and preparation method thereof
The colon-targeted drug delivery system, which combines PEGylated recombinant human granulocyte colony-stimulating factor particles and traditional Chinese medicine polysaccharide peptide complexes, has solved the problem of leukopenia after chemotherapy, achieving the effect of rapidly increasing white blood cell count and reducing adverse reactions.
Patent Information
- Application Number
- CN202411230382.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-03
- Publication Date
- 2024-11-29
AI Technical Summary
Chemotherapy and radiotherapy often lead to leukopenia. Existing Chinese medicine treatments have limited efficacy and cannot meet the needs for rapid and comprehensive treatment. Furthermore, oral administration of recombinant human granulocyte colony-stimulating factor has degradation and permeability issues.
A composition for treating leukopenia after radiotherapy and chemotherapy was prepared by combining polyethylene glycol-modified recombinant human granulocyte colony-stimulating factor particles with traditional Chinese medicine polysaccharides and silk fibroin peptides, and by using a microbiome-triggered drug delivery system to achieve colon-targeted drug delivery. Combined with traditional Chinese medicine formulas that invigorate qi and nourish blood, warm yang and dispel cold.
It significantly increases white blood cell count, reduces adverse reactions, increases plasma albumin, hemoglobin and platelet levels, enhances patient compliance, shortens the duration of granulocytopenia, and reduces the risk of infection.
Smart Images

Figure BDA0005026998160000121
Abstract
Description
Technical Field
[0001] The present invention relates to the field of medical technology, and in particular to a composition for treating leukopenia after radiotherapy and chemotherapy and a preparation method thereof. Background Art
[0002] Cancer is a general term for a large class of malignant tumors. Cancer cells are characterized by unlimited and endless proliferation, which consumes a large amount of nutrients in the patient's body; cancer cells release a variety of toxins, causing a series of symptoms in the human body; cancer cells can also metastasize to various parts of the body to grow and reproduce, causing weight loss, weakness, anemia, loss of appetite, fever, and serious organ damage, etc. In contrast, there are benign tumors, which are easy to remove, generally do not metastasize or recur, and only have a squeezing and blocking effect on organs and tissues. However, cancer (malignant tumors) can also destroy the structure and function of tissues and organs, causing necrosis, bleeding and infection, and the patient eventually dies due to organ failure.
[0003] At present, chemotherapy and radiotherapy are commonly used methods of cancer treatment. However, chemotherapy and radiotherapy often lead to leukopenia. While killing cancer cells, they also damage normal tissues, especially inhibiting the hematopoietic function of the bone marrow, resulting in a continuous decrease in peripheral white blood cells. This condition not only hinders the continuation of chemotherapy and radiotherapy, but also can cause serious consequences. During chemotherapy and radiotherapy, a decrease in white blood cells is inevitable, because white blood cells are one of the most active cells in the human body and are very sensitive to chemotherapy and radiotherapy. Leukopenia refers to when the white blood cell count in a person's peripheral blood is continuously lower than 4.0×10 9 / L or less. The common causes of leukopenia are drugs, radiation or other chemical poisons. Leukopenia can lead to low immunity, loss of appetite, weakness in the limbs and other symptoms. After leukopenia occurs, patients do not need to panic, but should actively cooperate with various methods to increase white blood cells.
[0004] Patients can use traditional Chinese medicine to treat leukocytopenia caused by radiotherapy and chemotherapy. Current traditional Chinese medicine treatments have achieved certain results, but more effective prescriptions are still needed to meet the needs of rapid efficacy, treating both the symptoms and the root causes, and reducing tumor recurrence. Summary of the invention
[0005] The purpose of the present invention is to provide a composition for treating leukopenia after radiotherapy and chemotherapy and a preparation method thereof, which has low toxicity, reduces the number of administrations, improves patient compliance, can increase plasma albumin, hemoglobin, and platelets in postoperative patients, significantly improves leukopenia in patients with various malignant tumors, reduces adverse reactions during radiotherapy and chemotherapy, and has broad application prospects.
[0006] The technical solution of the present invention is achieved in this way:
[0007] The invention provides a composition for treating leukocytopenia after radiotherapy and chemotherapy. The composition is prepared from the following raw materials by weight: 5-15 parts of ginseng, 45-55 parts of astragalus, 25-35 parts of prepared rehmannia, 5-15 parts of angelica, 25-35 parts of agrimony, 5-15 parts of cinnamon, 3-8 parts of aconite, 5-15 parts of ligusticum chuanxiong, 5-15 parts of antler glue and 5-15 parts of roasted liquorice.
[0008] As a further improvement of the present invention, it is prepared from the following raw materials by weight: 10 parts of ginseng, 50 parts of astragalus, 30 parts of cooked rehmannia, 10 parts of angelica, 30 parts of agrimony, 10 parts of cinnamon, 6 parts of aconite, 10 parts of chuanxiong, 10 parts of antler glue, and 10 parts of roasted licorice.
[0009] As a further improvement of the present invention, it also includes pegylated recombinant human granulocyte stimulating factor.
[0010] The present invention further protects a method for preparing the above-mentioned composition for treating leukopenia after radiotherapy and chemotherapy, comprising the following steps:
[0011] S1. Preparation of Chinese herbal polysaccharides and Chinese herbal extracts: Ginseng, astragalus, rehmannia, angelica, agrimony, cinnamon, aconite, ligusticum chuanxiong, antler glue, and licorice are mixed and crushed to obtain Chinese herbal powder, added into water, heated and boiled for extraction, filtered, the solid residue is retained, ethanol is added to the filtrate for precipitation, the solid is collected, washed, and dried to obtain Chinese herbal polysaccharides, ethanol is recovered from the filtrate, and dried to obtain Chinese herbal extracts;
[0012] S2 fermentation: the solid residue in step S1 is added to water, sterilized, inoculated with Bacillus subtilis and Saccharomyces boulardii seed solution, fermented, filtered, freeze-dried, to obtain a fermentation product;
[0013] S3. Preparation of Chinese herbal polysaccharide / silk protein peptide complex: Chinese herbal polysaccharide and ferulic acid are added to water, NHS (N-hydroxysuccinimide) and EDC (1-ethyl-(3-dimethylaminopropyl) carbodiimide) are added, the reaction is activated, the silk protein peptide is added, the reaction is stirred, and the reaction is freeze-dried to obtain a Chinese herbal polysaccharide / silk protein peptide complex;
[0014] S4. Preparation of particles encapsulating PEGylated recombinant human granulocyte-stimulating factor: dissolve chitosan in acetic acid solution, adjust the pH value of the solution, add Chinese medicine polysaccharide / silk fibroin peptide complex, PEGylated recombinant human granulocyte-stimulating factor particles and calcium chloride, stir and mix evenly to obtain solution A, dissolve sodium alginate in water to obtain solution B; add solution A dropwise into solution B through a syringe, solidify at room temperature, centrifuge, wash, and freeze-dry to obtain particles encapsulating PEGylated recombinant human granulocyte-stimulating factor;
[0015] S5. Preparation of a composition for treating leukopenia after chemoradiotherapy: Evenly mix the particles of embedded PEGylated recombinant human granulocyte stimulating factor, Chinese herbal extracts, and fermentation products to prepare a composition for treating leukopenia after chemoradiotherapy.
[0016] As a further improvement of the present invention, the solid-liquid ratio of the Chinese medicine powder and water in step S1 is 1:7-10 g / mL, the heating and boiling extraction time is 3-5 hours, and ethanol is added to the filtrate until the ethanol content of the system is 70-80wt%.
[0017] As a further improvement of the present invention, the mass ratio of the solid residue to water in step S2 is 10:110-120, the inoculation amounts of the Bacillus subtilis and Saccharomyces boulardii seed solutions are 1-2 v / v% and 0.5-1.5 v / v%, respectively, and the bacterial content of the seed solution is 10 8 -10 9 cfu / mL, the fermentation culture conditions are 35-40°C, 100-200r / min, and the fermentation culture is 36-48h.
[0018] As a further improvement of the present invention, the mass ratio of the traditional Chinese medicine polysaccharide, ferulic acid, NHS, EDC, and silk fibroin peptide in step S3 is 10:2-3:7-10:3-5:3-4, the temperature of the activation reaction is 0-4°C, the time is 30-40min, and the stirring reaction time is 12-15h.
[0019] As a further improvement of the present invention, the concentration of the acetic acid solution in step S4 is 1-2wt%, the mass ratio of the chitosan, the traditional Chinese medicine polysaccharide / silk fibroin peptide complex, the pegylated recombinant human granulocyte-stimulating factor particles, calcium chloride, and sodium alginate is 10-12:10:7-10:0.5-1:15-20, and the pH value of the adjusted solution is 5.5-5.7.
[0020] As a further improvement of the present invention, the mass ratio of the embedded PEGylated recombinant human granulocyte stimulating factor particles, the traditional Chinese medicine extract, and the fermentation product in step S5 is 10:4-6:3-5.
[0021] As a further improvement of the present invention, the present invention specifically comprises the following steps:
[0022] S1. Preparation of Chinese herbal polysaccharides and Chinese herbal extracts: Ginseng, astragalus, rehmannia, angelica, agrimony, cinnamon, aconite, ligusticum chuanxiong, antler glue, and licorice are mixed and crushed to obtain Chinese herbal powder, which is added to water, wherein the solid-liquid ratio of the Chinese herbal powder to water is 1:7-10 g / mL, and the mixture is heated and boiled for extraction for 3-5 hours, filtered, and the solid residue is retained, ethanol is added to the filtrate until the ethanol content of the system is 70-80wt%, precipitated, solids are collected, washed, and dried to obtain Chinese herbal polysaccharides, and ethanol is recovered from the filtrate, dried, and Chinese herbal extracts are obtained;
[0023] S2. Fermentation: The solid residue in step S1 was added to water, sterilized, inoculated with Bacillus subtilis and Saccharomyces boulardii seed solution, the inoculation amounts were 1-2v / v% and 0.5-1.5v / v%, 35-40°C, 100-200r / min, fermented for 36-48h, filtered, freeze-dried, and a fermentation product was obtained;
[0024] The bacterial content of the bacterial seed liquid is 10 8 -10 9 cfu / mL;
[0025] S3. Preparation of Chinese herbal polysaccharide / silk fibroin peptide complex: 10 parts by weight of Chinese herbal polysaccharide and 2-3 parts by weight of ferulic acid were added to water, 7-10 parts by weight of NHS and 3-5 parts by weight of EDC were added, activated at 0-4°C for 30-40 minutes, 3-4 parts by weight of silk fibroin peptide were added, stirred for 12-15 hours, and freeze-dried to obtain a Chinese herbal polysaccharide / silk fibroin peptide complex;
[0026] S4. Preparation of particles encapsulating PEGylated recombinant human granulocyte-stimulating factor: dissolve 10-12 parts by weight of chitosan in 1-2wt% acetic acid solution, adjust the solution pH to 5.5-5.7, add 10 parts by weight of traditional Chinese medicine polysaccharide / silk protein peptide complex, 7-10 parts by weight of PEGylated recombinant human granulocyte-stimulating factor particles and 0.5-1 parts by weight of calcium chloride, stir and mix evenly to obtain solution A, dissolve 15-20 parts by weight of sodium alginate in water to obtain solution B; add solution A dropwise into solution B through a syringe, solidify at room temperature, centrifuge, wash, and freeze-dry to obtain particles encapsulating PEGylated recombinant human granulocyte-stimulating factor;
[0027] S5. Preparation of a composition for treating leukopenia after chemoradiotherapy: 10 parts by weight of particles of embedded PEGylated recombinant human granulocyte stimulating factor, 4-6 parts by weight of a Chinese herbal extract, and 3-5 parts by weight of a fermentation product are mixed evenly to prepare a composition for treating leukopenia after chemoradiotherapy.
[0028] The present invention has the following beneficial effects:
[0029] In the prescription of the present invention, ginseng greatly replenishes vital energy, astragalus, and cyperus rotundus improve physical fitness; prepared rehmannia nourishes blood and nourishes yin, replenishes essence and benefits marrow; angelica harmonizes blood, nourishes qi and blood, and nourishes qi and blood in combination with other medicines; herba agrimonii replenishes deficiency and strengthens body, detoxifies and kills insects; cinnamon is warming and nourishing, and has warming and nourishing effects; aconite replenishes fire and helps yang, dispels cold and relieves pain; ligusticum chuanxiong promotes blood circulation and qi, and is used for replenishing without stagnation; antler glue replenishes kidney and benefits essence and blood, supports sores and toxins, and is combined with other medicines to benefit essence and qi; and roasted liquorice replenishes spleen and benefits qi, and harmonizes medicinal properties. The prescription of the present invention replenishes qi and nourishes blood, warms yang and dispels cold, strengthens the body and eliminates evil, can improve plasma albumin, hemoglobin, and platelets in patients after surgery, has a significant improvement on leukopenia in patients with various malignant tumors, and reduces adverse reactions during radiotherapy and chemotherapy.
[0030] Recombinant human granulocyte colony stimulating factor is made by recombinant technology. It is a glycoprotein synthesized by fibroblasts, monocytes and endothelial cells. It can promote the maturation of neutrophils and stimulate the body's granulocyte colony-forming units. However, there are the following problems with the oral administration of this type of protein polypeptide drugs: first, the degradation of protein polypeptide drugs by gastric acid and various proteolytic enzymes in the digestive tract; second, large molecular protein polypeptide drug compounds are difficult to penetrate biological membranes to exert their efficacy. PEGylation can significantly prolong the half-life of recombinant human granulocyte colony stimulating factor in the body, reduce plasma clearance, thereby reducing the number of dosing times and improving patient compliance. Therefore, the present invention selects PEGylated recombinant human granulocyte colony stimulating factor.
[0031] The concentration of proteolytic enzymes in the colon is much lower than that in other sections of the digestive tract, and the drug stays in this area for a longer time. At the same time, the resistance of the colon wall to the penetration of macromolecules is also smaller than that of the small intestine, which is conducive to the full absorption of the drug. Therefore, the present invention prepares a particle of embedded PEGylated recombinant human granulocyte stimulating factor, and adopts a flora-triggered drug delivery system to achieve colon-targeted drug delivery. The enzymes produced by the colon flora act on the packaging material, resulting in the degradation of the packaging material, causing the drug to be released, while having no effect on the stability of the drug.
[0032] Lysozyme is easily produced in colonic flora, which can effectively hydrolyze the peptidoglycan of bacterial cell walls. Its hydrolysis site is the β-1,4 glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine. The substances that are easily hydrolyzed by lysozyme are mainly peptidoglycan structures. The present invention prepares Chinese medicine polysaccharides, reacts with chitosan and silk protein peptides, and the wall material prepared is similar to the peptidoglycan structure, which is easily hydrolyzed by lysozyme, and protein peptide drugs are embedded. It has the advantages of low toxicity and easy degradation by lysozyme, etc., and achieves the goal of targeted drug release. At the same time, Chinese medicine polysaccharides can also be absorbed by the human body after degradation, exerting drug efficacy, preventing the occurrence of neutropenia, reducing the degree of neutropenia, shortening the duration of granulocytopenia, and accelerating the recovery of granulocyte count, thereby reducing the risk of fever caused by combined infection.
[0033] The composition for treating leukopenia after radiotherapy and chemotherapy prepared by the present invention has low toxicity, reduces the number of administrations, improves patient compliance, can increase plasma albumin, hemoglobin, and platelets in patients after surgery, significantly improves leukopenia in patients with various malignant tumors, reduces adverse reactions during radiotherapy and chemotherapy, and has broad application prospects. DETAILED DESCRIPTION
[0034] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0035] Bacillus subtilis, 20 billion cfu / g, was purchased from Guangzhou Zhenwei Microbiology Technology Co., Ltd. Saccharomyces boulardii, 20 billion cfu / g, was purchased from Wuhan Lanabai Pharmaceutical Chemical Co., Ltd.
[0036] Bacillus subtilis and Saccharomyces boulardii seed solution: inoculate the strains into Goulburn medium, incubate at 38°C, 100 r / min, activate and culture for 18-24 hours, and obtain a medium with a bacterial count of 10 8 -10 9 cfu / mL of bacterial seed solution.
[0037] Silk fibroin peptide, with a protein content of >90%, was purchased from Wuhan Huaxiang Kejie Biotechnology Co., Ltd.
[0038] Chitosan was purchased from Guangdong Mingtong Biotechnology Co., Ltd.
[0039] Example 1
[0040] This embodiment provides a method for preparing a composition for treating leukopenia after radiotherapy and chemotherapy, which specifically comprises the following steps:
[0041] S1. Preparation of Chinese herbal polysaccharides and Chinese herbal extracts: 5g of ginseng, 45g of astragalus, 25g of rehmannia, 5g of angelica, 25g of agrimony, 5g of cinnamon, 3g of aconite, 5g of ligusticum chuanxiong, 5g of antler glue, and 5g of licorice were mixed and crushed to obtain Chinese herbal powder, which was added to water. The solid-liquid ratio of the Chinese herbal powder to water was 1:7g / mL. The mixture was heated and boiled for extraction for 3h, filtered, and the solid residue was retained. Ethanol was added to the filtrate until the ethanol content of the system was 70wt%, precipitated, the solid was collected, washed, and dried to obtain Chinese herbal polysaccharides. Ethanol was recovered from the filtrate, dried, and Chinese herbal extracts were obtained.
[0042] S2. Fermentation: The solid residue in step S1 was added to water, sterilized, inoculated with Bacillus subtilis and Saccharomyces boulardii seed solution, the inoculation amounts were 1v / v% and 0.5v / v%, 35°C, 100r / min, fermented for 36h, filtered, freeze-dried, and a fermentation product was obtained;
[0043] S3. Preparation of Chinese herbal polysaccharide / silk protein peptide complex: 10 g of Chinese herbal polysaccharide and 2 g of ferulic acid were added to 500 mL of water, 7 g of NHS and 3 g of EDC were added, activated at 0°C for 30 min, 3 g of silk protein peptide was added, stirred for 12 h, and freeze-dried to obtain a Chinese herbal polysaccharide / silk protein peptide complex;
[0044] S4. Preparation of particles encapsulating PEGylated recombinant human granulocyte-stimulating factor: dissolve 10g chitosan in 1L 1wt% acetic acid solution, adjust the solution pH to 5.5, add 10g Chinese medicine polysaccharide / silk protein peptide complex, 7g PEGylated recombinant human granulocyte-stimulating factor particles and 0.5g calcium chloride, stir and mix for 15min to obtain solution A, dissolve 15g sodium alginate in 2L water to obtain solution B; add solution A dropwise into solution B through a syringe, solidify at room temperature for 30min, centrifuge, wash, and freeze-dry to obtain particles encapsulating PEGylated recombinant human granulocyte-stimulating factor;
[0045] S5. Preparation of a composition for treating leukopenia after chemoradiotherapy: 10 g of PEGylated recombinant human granulocyte stimulating factor particles, 4 g of a Chinese herbal extract, and 3 g of a fermentation product were mixed and stirred for 20 minutes to prepare a composition for treating leukopenia after chemoradiotherapy.
[0046] Example 2
[0047] This embodiment provides a method for preparing a composition for treating leukopenia after radiotherapy and chemotherapy, which specifically comprises the following steps:
[0048] S1. Preparation of Chinese herbal polysaccharides and Chinese herbal extracts: 15g ginseng, 55g astragalus, 35g rehmannia, 15g angelica, 35g agrimony, 15g cinnamon, 8g aconite, 15g ligusticum, 15g antler glue, and 15g licorice were mixed and crushed to obtain Chinese herbal powder, which was added to water, wherein the solid-liquid ratio of the Chinese herbal powder to water was 1:10 g / mL, and the mixture was heated and boiled for extraction for 5h, filtered, and the solid residue was retained. Ethanol was added to the filtrate until the ethanol content of the system was 80wt%, and the mixture was precipitated, the solid was collected, washed, and dried to obtain Chinese herbal polysaccharides, and the filtrate was used to recover ethanol, dried, and obtain Chinese herbal extracts;
[0049] S2. Fermentation: The solid residue in step S1 was added to water, sterilized, inoculated with Bacillus subtilis and Saccharomyces boulardii seed solution, the inoculation amounts were 2v / v% and 1.5v / v%, respectively, at 40°C, 200r / min, fermented for 48h, filtered, freeze-dried, and a fermentation product was obtained;
[0050] S3. Preparation of Chinese herbal polysaccharide / silk protein peptide complex: 10 g of Chinese herbal polysaccharide and 3 g of ferulic acid were added to 500 mL of water, 10 g of NHS and 5 g of EDC were added, activated at 4°C for 40 min, 4 g of silk protein peptide was added, stirred for 15 h, and freeze-dried to obtain a Chinese herbal polysaccharide / silk protein peptide complex;
[0051] S4. Preparation of particles encapsulating PEGylated recombinant human granulocyte-stimulating factor: dissolve 12g chitosan in 1L 2wt% acetic acid solution, adjust the solution pH to 5.7, add 10g Chinese medicine polysaccharide / silk protein peptide complex, 10g PEGylated recombinant human granulocyte-stimulating factor particles and 1g calcium chloride, stir and mix for 15min to obtain solution A, dissolve 20g sodium alginate in 2L water to obtain solution B; add solution A dropwise into solution B through a syringe, solidify at room temperature for 30min, centrifuge, wash, and freeze-dry to obtain particles encapsulating PEGylated recombinant human granulocyte-stimulating factor;
[0052] S5. Preparation of a composition for treating leukopenia after chemoradiotherapy: 10 g of PEGylated recombinant human granulocyte stimulating factor particles, 6 g of a Chinese herbal extract, and 5 g of a fermentation product were stirred and mixed for 20 minutes to prepare a composition for treating leukopenia after chemoradiotherapy.
[0053] Example 3
[0054] This embodiment provides a method for preparing a composition for treating leukopenia after radiotherapy and chemotherapy, which specifically comprises the following steps:
[0055] S1. Preparation of Chinese herbal polysaccharides and Chinese herbal extracts: 10g ginseng, 50g astragalus, 30g rehmannia, 10g angelica, 30g agrimony, 10g cinnamon, 6g aconite, 10g ligusticum, 10g antler glue, 10g licorice root were mixed and crushed to obtain Chinese herbal powder, and added into water, wherein the solid-liquid ratio of the Chinese herbal powder to water was 1:8g / mL, and the mixture was heated and boiled for 4h, filtered, and the solid residue was retained, ethanol was added into the filtrate until the ethanol content of the system was 75wt%, precipitated, solid was collected, washed, and dried to obtain Chinese herbal polysaccharides, and ethanol was recovered from the filtrate, dried, and obtained Chinese herbal extracts;
[0056] S2. Fermentation: The solid residue in step S1 was added to water, sterilized, inoculated with Bacillus subtilis and Saccharomyces boulardii seed solution, the inoculation amounts were 1.5 v / v% and 1 v / v%, 37 ° C, 150 r / min, fermented for 42h, filtered, freeze-dried, and obtained a fermentation product;
[0057] S3. Preparation of Chinese herbal polysaccharide / silk protein peptide complex: 10 g of Chinese herbal polysaccharide and 2.5 g of ferulic acid were added to 500 mL of water, 8 g of NHS and 4 g of EDC were added, activated at 2°C for 35 min, 3.5 g of silk protein peptide was added, stirred for 13 h, and freeze-dried to obtain a Chinese herbal polysaccharide / silk protein peptide complex;
[0058] S4. Preparation of particles encapsulating PEGylated recombinant human granulocyte-stimulating factor: dissolve 11g chitosan in 1L 1.5wt% acetic acid solution, adjust the solution pH to 5.6, add 10g Chinese medicine polysaccharide / silk protein peptide complex, 8.5g PEGylated recombinant human granulocyte-stimulating factor particles and 0.7g calcium chloride, stir and mix for 15min to obtain solution A, dissolve 17g sodium alginate in 2L water to obtain solution B; add solution A dropwise into solution B through a syringe, solidify at room temperature for 30min, centrifuge, wash, and freeze-dry to obtain particles encapsulating PEGylated recombinant human granulocyte-stimulating factor;
[0059] S5. Preparation of a composition for treating leukopenia after chemoradiotherapy: 10 g of PEGylated recombinant human granulocyte stimulating factor particles, 5 g of a Chinese herbal extract, and 4 g of a fermentation product were stirred and mixed for 20 minutes to prepare a composition for treating leukopenia after chemoradiotherapy.
[0060] Example 4
[0061] Compared with Example 3, the difference is that the Bacillus subtilis seed liquid is not inoculated in step S2.
[0062] The details are as follows:
[0063] S2. Fermentation: The solid residue in step S1 is added to water, sterilized, and inoculated with 2.5 v / v% of Saccharomyces boulardii seed solution, at 37°C, 150 r / min, and fermented for 42 h, filtered, and freeze-dried to obtain a fermentation product.
[0064] Example 5
[0065] Compared with Example 3, the difference is that the Saccharomyces boulardii seed liquid is not inoculated in step S2.
[0066] The details are as follows:
[0067] S2. Fermentation: The solid residue in step S1 is added to water, sterilized, inoculated with Bacillus subtilis seed solution at an inoculation rate of 2.5 v / v%, 37°C, 150 r / min, fermented for 42 h, filtered, freeze-dried, and a fermentation product is obtained.
[0068] Comparative Example 1
[0069] Compared with Example 3, the difference is that no ferulic acid is added in step S3.
[0070] The details are as follows:
[0071] S3. Preparation of Chinese herbal polysaccharide / silk protein peptide complex: Add 12.5g of Chinese herbal polysaccharide into 500mL of water, add 8g of NHS and 4g of EDC, activate the reaction at 2℃ for 35min, add 3.5g of silk protein peptide, stir the reaction for 13h, freeze-dry, and obtain the Chinese herbal polysaccharide / silk protein peptide complex.
[0072] Comparative Example 2
[0073] Compared with Example 3, the difference is that no Chinese medicine polysaccharide is added in step S3.
[0074] The details are as follows:
[0075] S3. Preparation of the complex: 12.5 g of ferulic acid was added to 500 mL of water, 8 g of NHS and 4 g of EDC were added, and the reaction was activated at 2°C for 35 min. 3.5 g of silk fibroin peptide was added, and the reaction was stirred for 13 h. The complex was freeze-dried to obtain the complex.
[0076] Comparative Example 3
[0077] Compared with Example 3, the difference is that chitosan is not added in step S4.
[0078] The details are as follows:
[0079] S4. Preparation of particles encapsulating PEGylated recombinant human granulocyte-stimulating factor: dissolve 20g of Chinese medicine polysaccharide / silk protein peptide complex, 8.5g of PEGylated recombinant human granulocyte-stimulating factor particles and 0.7g of calcium chloride in 1L of water, and stir for 15min to obtain solution A; dissolve 17g of sodium alginate in 2L of water to obtain solution B; add solution A dropwise into solution B through a syringe, solidify at room temperature for 30min, centrifuge, wash, and freeze-dry to obtain particles encapsulating PEGylated recombinant human granulocyte-stimulating factor.
[0080] Comparative Example 4
[0081] Compared with Example 3, the difference is that no traditional Chinese medicine polysaccharide / silk fibroin peptide complex is added in step S4.
[0082] The details are as follows:
[0083] S4. Preparation of particles encapsulating PEGylated recombinant human granulocyte-stimulating factor: dissolve 21g of chitosan in 1L of 1.5wt% acetic acid solution, adjust the solution pH to 5.6, add 8.5g of PEGylated recombinant human granulocyte-stimulating factor particles and 0.7g of calcium chloride, stir and mix for 15min to obtain solution A, dissolve 17g of sodium alginate in 2L of water to obtain solution B; add solution A dropwise into solution B through a syringe, solidify at room temperature for 30min, centrifuge, wash, and freeze-dry to obtain particles encapsulating PEGylated recombinant human granulocyte-stimulating factor.
[0084] Comparative Example 5
[0085] Compared with Example 3, the difference is that no PEGylated recombinant human granulocyte stimulating factor particles are added in step S5.
[0086] The details are as follows:
[0087] S5. Preparation of a composition for treating leukopenia after chemoradiotherapy: 5 g of a Chinese herbal extract and 4 g of a fermentation product were stirred and mixed for 20 minutes to prepare a composition for treating leukopenia after chemoradiotherapy.
[0088] Comparative Example 6
[0089] Compared with Example 3, the difference is that no Chinese herbal medicine extract is added in step S5.
[0090] The details are as follows:
[0091] S5. Preparation of a composition for treating leukopenia after chemoradiotherapy: 10 g of particles of PEGylated recombinant human granulocyte stimulating factor and 4 g of fermentation product were stirred and mixed for 20 minutes to prepare a composition for treating leukopenia after chemoradiotherapy.
[0092] Comparative Example 7
[0093] Compared with Example 3, the difference is that no fermentation product is added in step S5.
[0094] The details are as follows:
[0095] S5. Preparation of a composition for treating leukopenia after chemoradiotherapy: 10 g of PEGylated recombinant human granulocyte stimulating factor particles and 5 g of a Chinese herbal extract were stirred and mixed for 20 min to prepare a composition for treating leukopenia after chemoradiotherapy.
[0096] Test Example 1
[0097] SPF Kunming mice weighing 22-23g were randomly divided into 11 groups, each with 10 mice: a control group, Example 1-5 groups, and Comparative Example 1-7 groups. The administration method was oral administration. The control group was administered with 25mL / kg / d of double distilled water by oral administration, and the Example 1-5 groups and Comparative Example 1-7 groups were administered with 25mL / kg / d of the corresponding aqueous suspension of the composition for leukopenia after radiotherapy and chemotherapy (concentration of 1mg / mL) by oral administration, and the administration was continued for 10 days.
[0098] On the seventh day, the mice were weighed and intraperitoneally injected with 100 mL / kg cyclophosphamide according to their body weight.
[0099] On the eleventh day, blood was collected from the eye sockets of each mouse to examine the number of cells, hemoglobin and reticulocytes. The differences between the drug-treated group and the control group were compared.
[0100] The results are shown in Table 1.
[0101] Table 1
[0102]
[0103] Note: Compared with the control group, P < 0.05.
[0104] As can be seen from the above table, the compositions for treating leukopenia after radiotherapy and chemotherapy prepared in Examples 1-3 of the present invention can significantly increase the number of peripheral blood leukocytes and the content of reticulocytes, and have little effect on the hemoglobin level.
[0105] On the twelfth day, the mice were weighed and then killed, and the thymus and spleen were weighed separately to calculate the thymus coefficient and spleen coefficient.
[0106] Thymus index = thymus weight mg / body weight g
[0107] Spleen index = spleen weight mg / body weight g
[0108] The results are shown in Table 2.
[0109] Table 2
[0110] Group Thymus index (mg / g) Spleen index (mg / g) Control group 1.58±0.34 4.28±0.77 Example 1 2.62±1.10 7.17±0.94 Example 2 2.65±1.02 7.21±1.14 Example 3 2.69±0.89 7.27±1.07 Example 4 2.45±1.98 7.01±1.35 Example 5 2.51±1.75 6.97±1.42 Comparative Example 1 2.50±1.82 6.90±1.38 Comparative Example 2 2.41±1.59 6.80±1.52 Comparative Example 3 2.52±1.64 6.97±1.47 Comparative Example 4 2.48±1.45 6.82±1.56 Comparative Example 5 2.28±1.39 6.57±1.32 Comparative Example 6 2.36±1.49 6.74±1.49 Comparative Example 7 2.37±1.58 6.78±1.45
[0111] Note: Compared with the control group, P < 0.05.
[0112] As can be seen from the above table, the compositions for treating leukopenia after radiotherapy and chemotherapy prepared in Examples 1-3 of the present invention can significantly counteract the shrinkage of the thymus and spleen of mice caused by cyclophosphamide.
[0113] Typical cases:
[0114] 1. Wang XX, female, 47 years old
[0115] Chief complaint: The patient sought medical attention due to fatigue and shortness of breath after cervical cancer surgery;
[0116] Physical examination: blood pressure 118 / 80, heart rate 73 beats / min, temperature 37℃, pale complexion, shortness of breath, laziness, decreased appetite, mental fatigue, cold limbs, edema of both limbs, groin pain, pale and fat tongue, weak and thready pulse;
[0117] Laboratory: decreased white blood cell count and hemoglobin.
[0118] Diagnosis: Postoperative sequelae of cervical cancer;
[0119] TCM Syndrome Differentiation: Qi and blood deficiency;
[0120] Treatment plan: replenishing qi and blood, strengthening the body and eliminating evil, orally taking the composition for leukopenia after radiotherapy and chemotherapy prepared in Example 3 of the present invention, 1 g per day;
[0121] Condition evaluation: After one month of treatment, the patient's fatigue and shortness of breath improved significantly, and his appetite improved significantly. Laboratory tests showed that the white blood cell count was normal.
[0122] 2. Li XX, female, 56 years old
[0123] Chief complaint: The patient came to see a doctor because of dizziness and fatigue after postoperative radiotherapy and chemotherapy for breast cancer;
[0124] Physical examination: blood pressure 120 / 73, 70 rate 65 times / min, body temperature 37.2℃, dizziness, tinnitus, emaciation, pale complexion, restless sleep, swelling of the left upper limb, pale tongue with white coating, and deep and fine pulse.
[0125] Laboratory: decreased white blood cells, decreased hemoglobin, low hematocrit, and decreased platelets;
[0126] Diagnosis: Postoperative chemotherapy sequelae of breast cancer, low white blood cell count;
[0127] TCM Syndrome Differentiation: Deficiency of both Qi and blood;
[0128] Treatment plan: replenishing qi and nourishing blood, orally taking the composition for leukopenia after radiotherapy and chemotherapy prepared in Example 3 of the present invention, 1 g per day;
[0129] Condition evaluation: After one month of treatment, all symptoms disappeared, and white blood cells and platelets were normal.
[0130] 3. Zhang XX, male, 82 years old
[0131] Chief complaint: The patient had gastric cancer and came to seek medical treatment because he felt tired, short of breath, palpitations and dizziness after radiotherapy and chemotherapy.
[0132] Physical examination: blood pressure 130 / 85, temperature 36.7℃, heart rate 80 beats / min, palpitations and dizziness, thin and dull figure, fatigue, shortness of breath and sweating, poor appetite, nausea and vomiting, dull pain in the stomach, pale tongue with teeth marks, weak and thready pulse, and decreased white blood cell count;
[0133] Treatment outcome: gastric cancer after chemoradiotherapy;
[0134] TCM diagnosis: Qi deficiency and spleen dampness;
[0135] Treatment plan: Strengthen the body and eliminate evil, replenish qi and nourish blood, strengthen the spleen and eliminate dampness, orally take the composition for leukopenia after radiotherapy and chemotherapy prepared in Example 3 of the present invention, 1g per day;
[0136] Evaluation: After one month of treatment, the white blood cell count was normal, shortness of breath and fatigue, and appetite were normal.
[0137] 4. Wang XX, male, 63 years old
[0138] Chief complaint: After liver cancer surgery, the patient came to see a doctor because of fatigue and loss of appetite due to chemotherapy;
[0139] Physical examination: blood pressure: 135 / 80, heart rate 75 / bpm, temperature 36.5℃, abdominal distension, pain, fatigue, poor appetite, loose stools, mild edema of the limbs, pale and fat tongue, weak and thready pulse;
[0140] Laboratory: decreased white blood cells and platelets;
[0141] Diagnosis: liver cancer, after chemotherapy;
[0142] TCM Syndrome Differentiation: Qi and Yin Deficiency;
[0143] Treatment plan: replenishing qi and blood, nourishing yin and tonifying the kidney, orally taking the composition for leukopenia after radiotherapy and chemotherapy prepared in Example 3 of the present invention, 1 g per day;
[0144] Evaluation: After one and a half months of treatment, the white blood cell count and platelet count were normal, and fatigue and poor appetite were significantly improved.
[0145] 5. Wang XX, female, 73 years old
[0146] Chief complaint: The patient came to the hospital for treatment due to fatigue, weakness and sweating after radiotherapy and chemotherapy after lung cancer surgery;
[0147] Physical examination: blood pressure 110 / 70, heart rate 65, temperature 37°C, dull pain in chest and back, weak cough, fatigue, sweating, pale tongue, deep and thin pulse;
[0148] Laboratory tests showed: decreased white blood cells;
[0149] Diagnosis: Lung cancer after chemotherapy;
[0150] TCM Syndrome Differentiation: Deficiency of both Qi and blood;
[0151] Treatment plan: nourishing qi and blood, orally taking the composition for leukopenia after radiotherapy and chemotherapy prepared in Example 3 of the present invention, 1 g per day;
[0152] Evaluation: After one month of treatment, fatigue, spontaneous sweating, and obvious improvement were observed, and the white blood cell count was normal.
[0153] 6. Gao XX, female, 48 years old
[0154] Chief complaint: The patient sought medical attention due to fatigue, shortness of breath, and dry throat after thyroid cancer surgery and chemotherapy;
[0155] Physical examination: blood pressure 125 / 83, heart rate 70 beats / min, temperature 36.8℃, fatigue, shortness of breath and sweating, dry mouth and throat, pale complexion, pale lips, loose stools, thin body, weak pulse;
[0156] Laboratory: decreased white blood cells and platelets;
[0157] Diagnosis: Postoperative thyroid cancer;
[0158] TCM Syndrome Differentiation: Qi and Yin Deficiency;
[0159] Treatment plan: replenishing qi and yin, strengthening spleen and replenishing blood, orally taking the composition for leukopenia after radiotherapy and chemotherapy prepared in Example 3 of the present invention, 1 g per day;
[0160] Evaluation: After one month of treatment, the white blood cell and platelet count were normal and weight loss was significantly improved.
[0161] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. A composition for treating leukopenia after radiotherapy and chemotherapy, characterized in that: The invention is prepared from the following raw materials by weight: 5-15 parts of ginseng, 45-55 parts of astragalus, 25-35 parts of prepared rehmannia, 5-15 parts of angelica, 25-35 parts of agrimony, 5-15 parts of cinnamon, 3-8 parts of aconite, 5-15 parts of chuanxiong, 5-15 parts of antler glue and 5-15 parts of roasted licorice.
2. The composition for treating leukopenia after chemoradiotherapy according to claim 1, characterized in that: The medicine is prepared from the following raw materials by weight: 10 parts of ginseng, 50 parts of astragalus, 30 parts of cooked rehmannia, 10 parts of angelica, 30 parts of agrimony, 10 parts of cinnamon, 6 parts of aconite, 10 parts of chuanxiong, 10 parts of antler glue, and 10 parts of roasted liquorice.
3. The composition for treating leukopenia after chemoradiotherapy according to claim 1, characterized in that: Also included are pegylated recombinant human granulocyte-stimulating factor.
4. A method for preparing a composition for treating leukopenia after chemoradiotherapy according to any one of claims 1 to 3, characterized in that: The following steps are involved: S1. Preparation of Chinese herbal polysaccharides and Chinese herbal extracts: Ginseng, astragalus, rehmannia, angelica, agrimony, cinnamon, aconite, ligusticum chuanxiong, antler glue, and licorice are mixed and crushed to obtain Chinese herbal powder, added into water, heated and boiled for extraction, filtered, the solid residue is retained, ethanol is added to the filtrate for precipitation, the solid is collected, washed, and dried to obtain Chinese herbal polysaccharides, ethanol is recovered from the filtrate, and dried to obtain Chinese herbal extracts; S2 fermentation: the solid residue in step S1 is added to water, sterilized, inoculated with Bacillus subtilis and Saccharomyces boulardii seed solution, fermented, filtered, freeze-dried, to obtain a fermentation product; S3. Preparation of Chinese herbal polysaccharide / silk fibroin peptide complex: adding Chinese herbal polysaccharide and ferulic acid to water, adding NHS and EDC, activating the reaction, adding silk fibroin peptide, stirring the reaction, freeze-drying, and preparing the Chinese herbal polysaccharide / silk fibroin peptide complex; S4. Preparation of particles encapsulating PEGylated recombinant human granulocyte-stimulating factor: dissolve chitosan in acetic acid solution, adjust the pH value of the solution, add Chinese medicine polysaccharide / silk fibroin peptide complex, PEGylated recombinant human granulocyte-stimulating factor particles and calcium chloride, stir and mix evenly to obtain solution A, dissolve sodium alginate in water to obtain solution B; add solution A dropwise into solution B through a syringe, solidify at room temperature, centrifuge, wash, and freeze-dry to obtain particles encapsulating PEGylated recombinant human granulocyte-stimulating factor; S5. Preparation of a composition for treating leukopenia after chemoradiotherapy: Evenly mix the particles of embedded PEGylated recombinant human granulocyte stimulating factor, Chinese herbal extracts, and fermentation products to prepare a composition for treating leukopenia after chemoradiotherapy.
5. The preparation method according to claim 4, characterized in that: In step S1, the solid-liquid ratio of the Chinese medicine powder to water is 1:7-10 g / mL, the heating and boiling extraction time is 3-5 hours, and ethanol is added to the filtrate until the ethanol content of the system is 70-80 wt%.
6. The preparation method according to claim 4, characterized in that: The mass ratio of the solid residue to water in step S2 is 10:110-120, the inoculation amounts of the Bacillus subtilis and Saccharomyces boulardii seed solutions are 1-2 v / v% and 0.5-1.5 v / v%, respectively, and the bacterial content of the seed solution is 10 8 -10 9 cfu / mL, the fermentation culture conditions are 35-40°C, 100-200r / min, and the fermentation culture is 36-48h.
7. The preparation method according to claim 4, characterized in that: In step S3, the mass ratio of the traditional Chinese medicine polysaccharide, ferulic acid, NHS, EDC and silk fibroin peptide is 10:2-3:7-10:3-5:3-4, the temperature of the activation reaction is 0-4°C, the time is 30-40min, and the stirring reaction time is 12-15h.
8. The preparation method according to claim 4, characterized in that: The concentration of the acetic acid solution in step S4 is 1-2wt%, the mass ratio of the chitosan, the traditional Chinese medicine polysaccharide / silk fibroin peptide complex, the pegylated recombinant human granulocyte stimulating factor particles, calcium chloride, and sodium alginate is 10-12:10:7-10:0.5-1:15-20, and the pH value of the adjusted solution is 5.5-5.
7.
9. The preparation method according to claim 4, characterized in that: The mass ratio of the embedded PEGylated recombinant human granulocyte stimulating factor particles, the traditional Chinese medicine extract, and the fermentation product in step S5 is 10:4-6:3-5.
10. The preparation method according to claim 4, characterized in that: The specific steps include: S1. Preparation of Chinese herbal polysaccharides and Chinese herbal extracts: Ginseng, astragalus, rehmannia, angelica, agrimony, cinnamon, aconite, ligusticum chuanxiong, antler glue, and licorice are mixed and crushed to obtain Chinese herbal powder, which is added to water, wherein the solid-liquid ratio of the Chinese herbal powder to water is 1:7-10 g / mL, and the mixture is heated and boiled for extraction for 3-5 hours, filtered, and the solid residue is retained, ethanol is added to the filtrate until the ethanol content of the system is 70-80wt%, precipitated, solids are collected, washed, and dried to obtain Chinese herbal polysaccharides, and ethanol is recovered from the filtrate, dried, and Chinese herbal extracts are obtained; S2. Fermentation: The solid residue in step S1 was added to water, sterilized, inoculated with Bacillus subtilis and Saccharomyces boulardii seed solution, the inoculation amounts were 1-2v / v% and 0.5-1.5v / v%, 35-40°C, 100-200r / min, fermented for 36-48h, filtered, freeze-dried, and a fermentation product was obtained; The bacterial content of the bacterial seed liquid is 10 8 -10 9 cfu / mL; S3. Preparation of Chinese herbal polysaccharide / silk fibroin peptide complex: 10 parts by weight of Chinese herbal polysaccharide and 2-3 parts by weight of ferulic acid were added to water, 7-10 parts by weight of NHS and 3-5 parts by weight of EDC were added, activated at 0-4°C for 30-40 minutes, 3-4 parts by weight of silk fibroin peptide were added, stirred for 12-15 hours, and freeze-dried to obtain a Chinese herbal polysaccharide / silk fibroin peptide complex; S4. Preparation of particles encapsulating PEGylated recombinant human granulocyte-stimulating factor: dissolve 10-12 parts by weight of chitosan in 1-2wt% acetic acid solution, adjust the solution pH to 5.5-5.7, add 10 parts by weight of traditional Chinese medicine polysaccharide / silk protein peptide complex, 7-10 parts by weight of PEGylated recombinant human granulocyte-stimulating factor particles and calcium chloride, stir and mix evenly to obtain solution A, dissolve 15-20 parts by weight of sodium alginate in water to obtain solution B; add solution A dropwise into solution B through a syringe, solidify at room temperature, centrifuge, wash, and freeze-dry to obtain particles encapsulating PEGylated recombinant human granulocyte-stimulating factor; S5. Preparation of a composition for treating leukopenia after chemoradiotherapy: 10 parts by weight of particles of embedded PEGylated recombinant human granulocyte stimulating factor, 4-6 parts by weight of a Chinese herbal extract, and 3-5 parts by weight of a fermentation product are mixed evenly to prepare a composition for treating leukopenia after chemoradiotherapy.
Citation Information
Patent Citations
Pharmaceutical composition for treating thrombocytopenia and preparation method thereof
CN103006883A
Traditional Chinese medicine composition for treating hyperthyroidism merger leukopenia
CN103536694A
Chinese traditional medicine composition for treating cancer and its preparation
CN1544047A
Shiweifuzheng medicine for tonifying qi and blood, warning yang and strengthening spleen and its prepn process
CN1682992A
